Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04725786
What this trial is testing

Clinical Relevance of Thoracic Echography for the Early Diagnosis of Interstitial Lung Disease in Systemic Scleroderma - Pilot Study

Who this might be right for
Systemic Sclerosis
University Hospital, Tours 30
Not applicableLooking for participantsNCT07236970
What this trial is testing

Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis

Who this might be right for
Pulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH
Alejandro Cruz Utrilla 350
Large-scale testing (Phase 3)Study completedNCT00070590
What this trial is testing

Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma

Who this might be right for
Pulmonary FibrosisScleroderma, Systemic
Actelion 132
Post-approval studies (Phase 4)Study completedNCT01051960
What this trial is testing

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

Who this might be right for
Systemic SclerosisShortness of BreathPulmonary Hypertension
University of California, Los Angeles 12
Not applicableEnded earlyNCT02556697
What this trial is testing

In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients

Who this might be right for
Pulmonary DiseasePulmonary Emphysema
University Hospital, Rouen 9
Not applicableUnknownNCT03508375
What this trial is testing

Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis

Who this might be right for
Systemic Scleroderma
Assistance Publique Hopitaux De Marseille 75
Large-scale testing (Phase 3)Study completedNCT00984932
What this trial is testing

Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension

Who this might be right for
Systemic Sclerosis
University of Alexandria 40
Testing effectiveness (Phase 2)Ended earlyNCT05339087
What this trial is testing

Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH

Who this might be right for
Pulmonary Vascular DisorderPrimary Pulmonary HypertensionSystemic Sclerosis+1 more
Heidelberg University 35
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Early research (Phase 1)Study completedNCT02426229
What this trial is testing

Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma

Who this might be right for
SclerodermaInterstitial Lung Disease
Medical University of South Carolina 15
Large-scale testing (Phase 3)Looking for participantsNCT06716606
What this trial is testing

Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Who this might be right for
Connective Tissue Diseases
GlaxoSmithKline 514
Not applicableUnknownNCT05345795
What this trial is testing

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
Central Hospital, Nancy, France 600
Post-approval studies (Phase 4)UnknownNCT05505409
What this trial is testing

Efficacy and Safety of Pirfenidone in CTD-ILD

Who this might be right for
PirfenidoneConnective Tissue DiseasesInterstitial Lung Disease
Qilu Hospital of Shandong University 120
Not applicableUnknownNCT00617487
What this trial is testing

Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Systemic SclerosisPulmonary Arterial Hypertension
Fondazione IRCCS Policlinico San Matteo di Pavia 200
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Early research (Phase 1)Ended earlyNCT03656627
What this trial is testing

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Who this might be right for
Autoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more
Alliance Foundation Trials, LLC. 7
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableUnknownNCT00453752
What this trial is testing

Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Medical University of Warsaw 100
Large-scale testing (Phase 3)Looking for participantsNCT06297096
What this trial is testing

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

Who this might be right for
Systemic SclerosisInterstitial Lung Disease
National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 86
Not applicableWithdrawnNCT01202045
What this trial is testing

Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients

Who this might be right for
Scleroderma, SystemicHypertension, Pulmonary
Paul Farand
Next Page